Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events

计划入组 100,000 人 · 首次发布于 2020 年 2 月 21 日

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

计划入组 650 人 · 首次发布于 2024 年 6 月 7 日

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

计划入组 200 人 · 首次发布于 2024 年 10 月 16 日

Adipose stem cell therapies (K-STEMCELL)

NK cell therapies (Wugen)

T cell therapies(RootPath)

BIONTECH CELL & GENE THERAPIES GMBH

Sweden

BeCare Link, LLC

United States

WALDEMAR LINK GmbH & Co. KG

Germany

Link Cell Therapies Emerges from Stealth with $60M Series A to Advance Logic-Gated CAR-T Platform

CMS Access Model Offers Hope for Cell and Gene Therapies in Sickle Cell Disease

Large-Scale Study Confirms Safety of CAR T-Cell Therapy: No Link to Secondary Cancers Found